Community protocol · AHK-Cu
A complete substance profile covering documented community themes, scientific context and explicit safety boundaries. Missing or non-standardised data are not replaced with estimates.
Also known as: Copper tripeptide AHK · Alanine-Histidine-Lysine copper
Sources checked: 27 August 2026
This page documents and evaluates online community information. It is not medical or therapeutic advice, individual counselling or an invitation to use Ipamorelin. It is not approved for the uses described here.
No medical, therapeutic or individual recommendation. Information is provided without warranty and used at your own risk. No liability for calculation errors, use, contamination, interactions or consequences.
Quick context
Discussed mainly in cosmetic skin and hair models; medicinal benefit and safety are unconfirmed.
No generally accepted approved dose exists. Online amounts vary by material, purity, route and source and prove neither safety nor efficacy.
Amounts, timing and cycles
No generally accepted approved dose exists. Online amounts vary by material, purity, route and source and prove neither safety nor efficacy.
Different amounts circulate online; no regulator-confirmed safe or effective dose exists.
Profile evidence level: preclinical.
Community claims about time of day, fasting windows or training intervals are not validated clinical standards.
No individual recommendation.
Cycles and breaks are community constructs and do not prevent adverse effects or unknown long-term consequences.
No individual recommendation.
No matching detail page found in the reference source
The external page is used only to document community claims. Advertising and affiliate material were excluded; its content is neither approval nor proof of quality.
Reconstitution and U-100 conversion
Reconstitution is not generally applicable to this substance or product class. Form, concentration and handling must come from the exact authentic product and its official labelling.
Reconstitution is not generally applicable to this substance or product class. Form, concentration and handling must come from the exact authentic product and its official labelling.
Mechanism and research questions
AHK-Cu is classified as “Copper-binding tripeptide studied in skin and hair models”. Discussed mainly in cosmetic skin and hair models; medicinal benefit and safety are unconfirmed. This describes the investigated pathway but does not validate a community use, amount, route or combination.
This studies how a short peptide binds copper ions and may support cell signalling in skin tissue, similar to a transport container for an important trace element. Collagen markers and cell activity in skin models are measured.
This examines how signals affect collagen and other structural proteins that give skin its firmness and elasticity, similar to studying the scaffolding beneath a building's surface. Researchers typically measure collagen production and skin structure in laboratory skin models.
This studies how a peptide influences the migration of cells toward an injury site, similar to workers rushing to a construction site. Speed and extent of cell migration are measured in lab models.
These themes describe discussion and vendor claims. They do not prove benefit, safety, product identity or suitable use.
Users exchange personal impressions of skin appearance, wrinkle depth, or hair growth after using cosmetically marketed peptides, usually based on their own photos rather than measurement devices. Such subjective impressions and marketing claims are not proof of a confirmed effect.
Vendors often advertise products with broad efficacy claims, comparison tables against competitors, and customer quotes. Such marketing statements are driven by sales interest and do not constitute independent scientific proof of efficacy.
Discussion covers which vendors are seen as more trustworthy and how purity test results differ between batches. Such community assessments are based on limited samples and do not replace independent lab testing of each individual batch.
Adverse effects and risk boundaries
Exclusion groups and professional assessment
Monitoring and laboratory markers
Evidence boundary
Confirmed medicinal benefit has not yet been established.
Published evidence
Available data come mostly from animal or cell models; robust human efficacy and safety data are lacking.
AHK-Cu is discussed mainly in cosmetic hair and skin models, while GHK-Cu is studied more broadly around skin matrix and collagen signalling.
Storage and stability
Troubleshooting and error sources
Regulatory status and WADA
No FDA- or EMA-approved medicinal product; efficacy and safety are not established.
WADA 2026
The atlas has no explicit WADA flag for this profile. That does not automatically mean every form, route or related class is permitted in sport.
WADA — 2026 Prohibited ListComparisons and related profiles
Combinations / stacks
Frequently asked questions
No. This page separates approved product information, study protocols and community information. No number or calculator is an individual dosing recommendation.
No. It only converts mass, volume and syringe scale. It cannot check identity, purity, sterility, stability, solvent or medical suitability.
Safety of a combination cannot be inferred from a single-substance profile. Overlapping pathways, medicines and undefined blends can increase risk.
For approved medicines, the current prescribing information and treating professional control. For research substances, conflict shows that no dependable self-use standard exists.
No. Anecdotes can generate questions but do not replace controlled studies, regulatory review, or identity and quality testing.
Sources and evidence layers
Primary sources and official registries take priority. The community reference is labelled separately.
